Virios Therapeutics Announces Termination Of At-The-Market Sales Agreement
Portfolio Pulse from Benzinga Newsdesk
Virios Therapeutics has announced the termination of its At-The-Market sales agreement. The company did not provide further details on the reasons behind this decision.

September 18, 2023 | 11:06 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Virios Therapeutics has terminated its At-The-Market sales agreement. This could potentially impact the company's stock price.
The termination of the At-The-Market sales agreement could potentially lead to a decrease in the company's stock price. Investors may perceive this as a negative development, leading to a sell-off. However, the actual impact will depend on the reasons behind this decision, which were not provided.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100